| 000 | 00967 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517003010.0 | ||
| 264 | 0 | _c20150902 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1744-7674 | ||
| 024 | 7 |
_a10.1517/13543776.2014.964686 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLv, Peng-Cheng | |
| 245 | 0 | 0 |
_aEGFR-binding peptide: a patent evaluation of WO2014002836. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic patents _cDec 2014 |
||
| 300 |
_a1409-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPatents as Topic |
| 650 | 0 | 4 | _aPeptide Library |
| 700 | 1 | _aZhu, Hai-Liang | |
| 773 | 0 |
_tExpert opinion on therapeutic patents _gvol. 24 _gno. 12 _gp. 1409-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543776.2014.964686 _zAvailable from publisher's website |
| 999 |
_c24363630 _d24363630 |
||